Atlas Trials

A Study to Evaluate the Long-Term Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's Disease

Clinical trial NCT05668013 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05668013
Sponsor
Teva Branded Pharmaceutical Products R&D LLC
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Crohn DiseaseColitis, Ulcerative
Start date
2023-01-11
Primary completion
2026-01-05
Enrollment
247

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.